Ten-minute tests get €2m investment

Kevin Healy, Bank of Ireland; Margot Marsden, Enterprise Ireland; Dawn Walsh, Kernel Capital; and Brendan Farrell, HiberGene
Kevin Healy, Bank of Ireland; Margot Marsden, Enterprise Ireland; Dawn Walsh, Kernel Capital; and Brendan Farrell, HiberGene

- Company:Hibergene Diagnostics

- Done deal:€2 million

- The clincher:“There is a significant market need for accurate, rapid, cost-effective and simple to use near-patient clinical testing for critical care infectious diseases.” – Orla Rimmington, partner, Kernel Capital

Dublin med-tech firm HiberGene Diagnostics has closed a €2 million funding round to bring to market its first two products.

A ...